Skip to main content

ニュース

Updates about Leica Biosystems.

BOND-RX-_-NanoString-Geo-MX-DSP-AUTOMATED-PROFILING-Banner
Published: 1 March 2022

SEATTLE, USA and MELBOURNE, AUSTRALIA. March 1st Leica Biosystems continues to advance its relationship with NanoString Technologies Inc., supporting translational research to build confidence in reproducibility and throughput while minimizing manual steps and reducing hands-on time with the…

csm_Leica_Biosystems
Published: 3 February 2022

Solution enables laboratory managers to optimize their tissue processor workflow. NUSSLOCH, GERMANY, FEB 1, 2022. Leica Biosystems is proud to add a new offering to its dualretort tissue processer portfolio: the HistoCore PEGASUS is now available in North American geographies. Building on more than…

csm_Leica_Biosystems
Published: 31 January 2022

CAMBRIDGE, MASS., JANUARY 31, 2022. Companion diagnostic supports patient identification and enrollment into clinical trials of Leap Therapeutics‘ DKK1 inhibitor, DKN-01 Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (Nasdaq: LPTX), a…

Published: 17 December 2021

1 Overview On or about December 10, 2021, a vulnerability was disclosed in the Apache Log4J software, which is a common logging system used by many applications built on Java. The vulnerability is commonly known as “Log4Shell.” More information on this vulnerability is available at https://logging.…

csm_Leica_Biosystems
Published: 2 August 2021

by Chad Salinas, Vice President, AI and Machine Learning Artificial Intelligence is exponentially increasing its impact on healthcare. As deep learning is mastering computer vision tasks, its application to digital pathology is natural, with the promise of aiding in routine reporting and…

leica-biosystems-achieves-first-in-vitro-diagnostics-regulation-certificate
Published: 9 July 2021

Leica Biosystems is on track to align its portfolio of instrumentation and consumables with the In Vitro Diagnostics Regulation (IVDR) that comes into effect May of 2022. Internal technical and operations teams, in partnership with Quality & Regulatory Affairs, are taking steps to ensure that…

csm_Leica_Biosystems
Published: 28 June 2021

e-IFU is legislated from August 1st, 2021 in Japan. LBS Japan will insert the IFU in the IVD package until July 30th, 2021 under this circumstances. We won’t insert the hard copy of IFU in the package after August 1st, 2021. Please use e-IFU application provided by MHLW on the barcode of the…

csm_Leica_Biosystems
Published: 17 June 2021

VISTA, CA –June 17, 2021 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that its Next Generation Aperio GT 450 DX scanner now supports DICOM imaging. Working closely in partnership with Leeds Teaching Hospital NHS as part of the National Pathology Imaging Co-…

ESDIP
Published: 2 May 2021

Leica Biosystems, a global leader in pathology workflow solutions, becomes a diamond sponsor and announces the start of a collaboration with the European Society for Digital and Integrative Pathology (ESDIP) to promote digital pathology adoption across Europe. "Building bridges between industry and…